Family Medicine Doctors in Frankfort, MI Accepting Medicare

3 Family Medicine doctors found. Showing 1 - 3

Gerard J Mahoney, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 826 Forest Ave, Frankfort, MI 49635 Phone: 231-352-5285    Fax: 231-352-6384

Nancy Lynn Smith, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1360 Bellows Ave, Frankfort, MI 49635 Phone: 231-352-2200

Dr. Douglas James Coles, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 917 Main Street, Frankfort, MI 49635 Phone: 231-352-7103    Fax: 231-352-7105

News Archive

Direct-to-consumer ‘low-T' medication advertising increases prescriptions but may not improve health

Direct-to-consumer advertising for drugs to treat testosterone deficiency - or "low T" - increases prescriptions to men for hormone-replacement therapies but may not improve their health, UC Davis physician Richard Kravitz said in an editorial published in the March 21 issue of the Journal of the American Medical Association.

Outreach effort moves forward despite Sebelius controversy

Families USA Executive Director Ron Pollack tells CQ Healthbeat that the flap won't prevent a robust effort by the nonprofit group, Enroll America, to sign up the uninsured. Meanwhile, White House Press Secretary Jay Carney draws parallels to earlier allegations about President Barack Obama's birth certificate.

Understanding potential of illicit drug ketamine in treating depression

Advancing the understanding and treatment of psychiatric disorders is a principal goal of neuroscientists. As mental disorders are the leading cause of disabilities worldwide, it is concerning that there are few effective therapeutics on the market due to the lack of knowledge regarding pathophysiology.

Silence Therapeutics receives patent for RNA silencing method

Silence Therapeutics plc announces the issuance of United States patent 7,772,203, titled "Methods and Compositions for Controlling Efficacy of RNA Silencing," by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of enhancing RNA silencing with a double stranded RNA interference (RNAi) agent. The patent's RNA silencing method claims include coverage for the administering of a pharmaceutical composition containing short interfering RNA (siRNA), micro RNA (miRNA), pre-miRNA or short hairpin (shRNA) molecules. Silence believes the proprietary structural modification techniques covered in this patent will play a key role in increasing the potential therapeutic efficacy of RNAi therapeutics.

Cardiovascular disease in COVID-19

The current COVID-19 pandemic is a primarily respiratory illness, manifesting with severe hypoxia and often progressing to acute respiratory distress syndrome (ARDS) and death. However, it is also known to be linked to a wide range of cardiovascular (CV) manifestations that are associated with a very poor prognosis.

Read more Medical News

› Verified 7 days ago